Delivery and controlled release abilities of chitosan/carboxymethylcellulose micropolyelectrolyte complexes (PECs) toward niacinamide (vitamin B3).

Int J Biol Macromol

Equipe de Estudo de Materiais Alimentares (E(2)MA), Departamento de Tecnologia de Alimentos (DTA), Universidade de Viçosa (UFV), CEP 36570-900 Viçosa, MG, Brazil. Electronic address:

Published: December 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The administration of bioactive compounds presents challenges due to the numerous physiological barriers in the gastrointestinal tract. To deal with one of these challenges, chitosan (CHS)/carboxymethylcellulose (CMC) micropolyelectrolyte complexes (micro-PECs) were developed without the use of crosslinking agents to carry niacinamide, a model hydrophilic bioactive agent. A Box-Behnken design was used to study the effects of processing time (X = 60, 120 or 180 min), pH (X = 3, 4 or 5) and niacinamide concentration (X = 0.02, 0.04 and 0.06, g·L) on the encapsulation efficiency (Y) and loading capacity (Y) of niacinamide by CMC/CHS micro-PECs. The encapsulation efficiency (Y) varied from 0.86 % to 80.78 %, whereas the loading capacity (Y2) varied between 0.03 % and 3.89 %. The digestibility of CMC/CHS micro-PECs containing niacinamide was evaluated in vitro via a static gastrointestinal model. Empirical models (Zero Order, First Order, Higuchi and Korsemeyer-Peppas) were fitted to the niacinamide release kinetics data. The zero-order model exhibited the best fit across all points (gastric and enteric digestion), with low zero-order constants (K) ~ 0.002-0.003, indicating a regular and subdued release rate in all cases. These results highlight the applicability of CMC/CHS micro-PECs as an efficient, novel oral delivery system, surpassing conventional approaches by offering a sustained release and high encapsulation efficiency, without needing any additional chemical crosslinking agent for their obtention.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2024.137848DOI Listing

Publication Analysis

Top Keywords

encapsulation efficiency
12
cmc/chs micro-pecs
12
micropolyelectrolyte complexes
8
loading capacity
8
niacinamide
6
delivery controlled
4
release
4
controlled release
4
release abilities
4
abilities chitosan/carboxymethylcellulose
4

Similar Publications

Indole-3-carboxaldehyde (I3A), a microbial tryptophan metabolite, exhibits significant immunomodulatory activity at the host-microbial interface. However, its rapid transformation into metabolites like indole-3-carboxylic acid (I3CA) raises questions about their therapeutic potential. This study aimed to evaluate the pharmacological contributions of I3CA through the development of a proper delivery strategy.

View Article and Find Full Text PDF

Acute lung injury (ALI) is characterized by the excessive accumulation of reactive oxygen species (ROS), which triggers a severe inflammatory cascade and the destruction of the alveolar-capillary barrier, leading to respiratory failure and life-threatening outcomes. Considering the limitations and adverse effects associated with current therapeutic interventions, developing effective and safe strategies that target the complex pathophysiological mechanisms of ALI is crucial for improving patient outcomes. Herein, we developed an inhalable, multifunctional nanotherapeutic (MSCNVs@CAT) by encapsulating catalase (CAT) in mesenchymal-stem-cell-derived nanovesicles (MSCNVs).

View Article and Find Full Text PDF

Natural products have emerged as a vital source of active ingredients in medicine, food, and cosmetics due to their unique biological activities, safety profiles, and sustainability. However, most bioactive compounds in natural products are intensely bitter, limiting their use in pharmaceuticals and foods. The bitter taste attributes vary markedly among different compound classes, predominantly due to their structural characteristics.

View Article and Find Full Text PDF

Nimodipine (NMP), a poorly water-soluble small-molecule agent, demonstrates notable therapeutic limitations in addressing cerebral vasospasm secondary to subarachnoid hemorrhage (SAH). Owing to its inherent physicochemical properties characterized by low oral bioavailability, rapid elimination half-life, and extensive first-pass metabolism, conventional formulations necessitate frequent dosing regimens to sustain therapeutic plasma concentrations. These pharmacological challenges collectively result in suboptimal patient adherence, marked plasma concentration fluctuations, and recurrent vascular irritation.

View Article and Find Full Text PDF

Ultrasmall MoC-MoO Heterojunction Coupled with Nitrogen-Doped Reduced Graphene for Boosting the Deep Oxidative Desulfurization of Fuel Oils.

Langmuir

September 2025

Engineering Technology Research Center of Preparation and Application of Industrial Ceramics of Anhui Province, Engineering Research Center of High-frequency Soft Magnetic Materials and Ceramic Powder Materials of Anhui Province, School of Chemistry and Material Engineering, Chaohu University, Chaoh

In this study, a MoC-MoO@NCrGO-900 composite catalyst comprising two-dimensional nitrogen-doped reduced graphene oxide (NCrGO) and ultrasmall molybdenum carbide-molybdenum dioxide (MoC-MoO) heterojunctions was synthesized. The optimized catalyst exhibited an outstanding oxidative desulfurization (ODS) performance. Specifically, a model oil containing 4000 ppm sulfur was completely desulfurized within 30 min, with a desulfurization efficiency of 98.

View Article and Find Full Text PDF